8
Participants
Start Date
December 1, 2011
Primary Completion Date
August 6, 2013
Study Completion Date
February 6, 2014
Eculizumab
1200 milligrams Eculizumab diluted in 0.9% NaCl to 5mg/mL for a total volume of 240 mL administered by IV infusion over 35 minutes in the operating room prior to organ reperfusion
Placebo
240 mL of 0.9% Sodium Chloride IV fluid given as placebo in the operating room prior to organ reperfusion
Mount Sinai Recanati/Miller Transplantation Institute, New York
Collaborators (1)
Alexion Pharmaceuticals, Inc.
INDUSTRY
Schroppel, Bernd, M.D.
INDIV